Zomedica Pharma

97 articles with Zomedica Pharma

• Zomedica Appoints New Chief Financial Officer

  3/17/2023

  Zomedica Corp., a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Peter L. Donato as its Chief Financial Officer, effective March 16, 2023.

• Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies

  1/18/2023

  Zomedica Corp. today announced a strategic restructuring of its existing development and commercialization agreements with Qorvo Biotechnologies for the Company's TRUFORMA line of products.

• Zomedica to Present at Sidoti Virtual Investor Conference January 18-19

  1/11/2023

  Zomedica Corp. announced Larry Heaton, CEO, will present and host one-on-one meetings with investors at the Sidoti January Virtual Investor Conference, taking place on January 18-19, 2023.

• Zomedica to Present at LD Micro Main Event XV Conference

  10/18/2022

  Zomedica Corp. announced that Larry Heaton, Zomedica's Chief Executive Officer, is scheduled to provide a company overview and its prospects for growth at the LD Micro Main Event XV Conference on October 25, 2022 at the Luxe Sunset Boulevard Hotelin Bel Air, California.

• Zomedica To Present at Dawson James Securities 7th Annual Small Cap Growth Conference

  9/28/2022

  Zomedica Corp. announced that Larry Heaton, Zomedica's Chief Executive Officer, is scheduled to provide a company overview and its prospects for growth at the Dawson James Securities Small Cap Growth Conference on October 12, 2022 at the Wyndham Grand Hotel in Jupiter, Florida.

• Zomedica Announces Launch of Free T4 Assay for Truforma(R) Diagnostic Platform

  9/13/2022

  Zomedica Corp., a veterinary health company offering novel diagnostic and therapeutic products for companion animals, announced the commercial launch of its newest assay - Free T4 - for the TRUFORMA In-Clinic Biosensor Testing Platform.

• Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference

  9/12/2022

  Zomedica Corp. announced that Larry Heaton, Chief Executive Officer, will provide a strategic update and insight into recent acquisitions at the upcoming H.C. Wainwright Global Investment Conference, scheduled for 3:00 pm ET on September 13, 2022.

• Zomedica Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse Association

  9/6/2022

  Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for equine and companion animals, is pleased to announce that the PulseVet system has been named the Official Shock Wave Therapy of the National Cutting Horse Association.

• Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors

  8/23/2022

  Zomedica Corp. announced that Pamela Nichols, DVM has been appointed to its Board of Directors and is joining the Audit and Governance committees.

• Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined Revenues

  8/15/2022

  The second quarter of 2022 was an exciting one for Zomedica as we both grew revenue organically and also executed on our acquisition strategy. We were pleased with our revenue growth to $4.2 million which reflects a 51% increase on a pro-forma basis, over the combined revenue of Zomedica and PulseVet as a standalone company of $2.8 million in the second quarter of last year.

• Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health

  7/18/2022

  Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, announced that it had acquired substantially all the assets of Assisi Animal Health LLC.

• Zomedica Announces New Global Manufacturing & Distribution Center

  7/7/2022

  Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, is expanding its manufacturing and distribution facility in Roswell Georgia, which will significantly increase capacity for production and distribution of its products.

• Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared

  7/6/2022

  Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, announced that the acquisition of the assets of Revo Squared LLC was recently completed.

• Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team

  6/28/2022

  Zomedica Corp. is honored to announce that the United States Equestrian Federation has named PulseVet as the Official Shock Wave Therapy Supplier of US Equestrian Team Veterinarians.

• Zomedica to Participate in Panel Discussion at Animal Health Investment Forum

  6/21/2022

  Zomedica Corp. announced that Greg Blair, Zomedica's Vice President of Business Development & Strategic Planning, will participate in a panel discussion and will provide a deep dive into how Zomedica's products and latest technologies are supporting veterinarians in the post-covid world at Animal Health, Nutrition & Technology Innovation USA scheduled in Boston, June 21-23, 2022.

• Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared

  6/15/2022

  Zomedica Corp. announced it has signed a definitive agreement to acquire substantially all of the assets of Revo Squared LLC.

• Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses

  6/13/2022

  Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, has initiated a study to evaluate shock wave therapy as a treatment for Exercised Induced Pulmonary Hemorrhage.

• Zomedica to Present at JMP Securities Life Sciences Conference - June 08, 2022

  6/8/2022

  Zomedica Corp., a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, is pleased to announce that Larry Heaton, Zomedica's Chief Executive Officer, will present at the JMP Securities Life Sciences Conference.

• Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary

  6/2/2022

  Zomedica Corp., a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Karen DeHaan-Fullerton as its General Counsel and Corporate Secretary.

• Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line

  5/19/2022

  Zomedica Corp. announced that it has purchased a $1.0 million convertible note from Structured Monitoring Products, Inc., makers of the VetGuardianTM wireless remote pet monitoring platform, and in connection therewith has acquired the option to act as a sales agent for SMP's platform.